Income Tax Expense (Benefit) of POINT Biopharma Global Inc. from 30 Jun 2020 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
POINT Biopharma Global Inc. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 30 Jun 2020 to 30 Sep 2023.
  • POINT Biopharma Global Inc. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2023 was $871,449, a 383% increase year-over-year.
  • POINT Biopharma Global Inc. Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2023 was $30,552,363, a 5862% increase year-over-year.
  • POINT Biopharma Global Inc. annual Income Tax Expense (Benefit) for 2022 was $31,292,875, a 10138% increase from 2021.
  • POINT Biopharma Global Inc. annual Income Tax Expense (Benefit) for 2021 was $305,658, a 248% increase from 2020.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

POINT Biopharma Global Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $30,552,363 $871,449 +$690,949 +383% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $29,861,414 $921,298 -$1,104,703 -602% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $30,966,117 $238,642 -$326,758 -371% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $31,292,875 $30,840,854 +$30,780,447 +50955% 01 Oct 2022 31 Dec 2022 10-K 27 Mar 2023 2022 FY
Q3 2022 $512,428 $180,500 +$99,456 +123% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $412,972 $183,405 +$59,623 +48% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $353,349 $88,116 +$47,691 +118% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $305,658 $60,407 01 Oct 2021 31 Dec 2021 10-K 27 Mar 2023 2022 FY
Q3 2021 $81,044 +$81,044 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $123,782 +$65,521 +112% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022 2022 Q2
Q1 2021 $40,425 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q3 2020 $0 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $58,261 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021 2021 Q2

POINT Biopharma Global Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $31,292,875 +$30,987,217 +10138% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2023 2022 FY
2021 $305,658 +$217,776 +248% 01 Jan 2021 31 Dec 2021 10-K 27 Mar 2023 2022 FY
2020 $87,882 01 Jan 2020 31 Dec 2020 10-K 25 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.